富瑞:上調長城汽車(2333.HK)目標價至5.2港元 重申“持有”評級
富瑞發佈報告稱,上調長城汽車(02333.HK)目標價,稱今年第三季度盈利表現遠好過市場預期,主要因為毛利率提高,由第二季度的13.6%,升至18.5%,目標價由4.8港元上調至5.2港元,評級重申“持有”。
另外,報告稱,長城2019年限制性股票與股票期權激勵計劃雖獲A股股東通過,但在H股類別股東大會上遭到否決,因此計劃拉到,長城汽車將不可以在3個月內再提交相關計劃,佔約22%的H股股東中參與投票,當中52%投票反對計劃,但並供提供原因,該行稱可能因為部分投資者認為計劃中的盈利要求太及太短,要求2019-2020年盈利各同比跌19%、增長7%及11%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.